NEW YORK, May 9 - As a June deadline for commercializing its 10,000 gene human microarrays looms, Corning’s Microarray Technology division is finding out what Affymetrix already knows: It’s tougher than you think to make a highly reproducible high-density microarray.

“We are still working the bugs out of the process, and working through the internal validation,” said Thomas Hinman, division vice president and general manager of CMT Life Sciences. “It has taken us longer than we wanted to.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.